NAGE
Niagen Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.50
+0.40%Forward multiples
Based on analyst estimates
- P/E forward
- 26.97x
- P/E 2026E
- 19.39x
- P/E 2027E
- 20.37x
- P/E 2028E
- 13.42x
- P/S forward
- 1.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.87x
- PEG TTM
- —
- Price / book
- 2.40x
- Price / sales
- 1.53x
- Price / cash flow
- 33.25x
Enterprise value
- Enterprise value
- $133.4M
- EV / sales
- 1.03x
- EV / EBITDA
- 7.28x
- EV / EBIT
- 15.49x
- Market cap
- $197.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026